Thursday, 27 February 2020

Japan News

  • Takeda makes massive changes in its organization

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Takeda Pharmaceutical announced the appointment of new senior leadership as well as the establishment of a new organization, realignment of current organizations, and change of o...Read more

  • Taiho to start ph III trial in colorectal cancer

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combination antimetabolite TAS-102 in June this year. RECOURSE is a randomi...Read more

  • Oramed gets Japanese patent for protein delivery

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2013

    Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, has received approval for a key patent by the Japanese Patent Office. The patent, titled "Methods and Composit...Read more

  • LG to co-develop biosimilars with Mochida

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2012

    Singapore: LG Life Sciences (LGLS) and Mochida Pharmaceutical have finalized the agreement to collaborate during the clinical trials and the registration phases of biosimilar products in ...Read more

  • Challenges that Japan pharma will face in 2014

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Japan, like all other developed markets, is facing the crunch of a slowing pharma industry. Furthermore, the pharma situation is about to get worse in Japan, according to Mr Fumiyoshi Sakai...Read more

  • Fujitsu brings medical data to smartphones, iPad

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: The new mobile integrated EMR technology, developed by Fujitsu, a Japanese multinational information technology equipment and services company, now enables patients to access the...Read more

  • Chugai expands in Singapore with research institute

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2012

    Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operations in Singapore on July 2, 2012. The opening ceremony was attended b...Read more

  • Eisai US to replace its president, CEO

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2014

    Singapore: Eisai, US, subsidiary of Tokyo-based Eisai, has appointed Mr Yuji Matsue as chairman and chief executive officer and Mr Shaji Procida as president and chief operating officer, ef...Read more

  • François-Xavier Roge is Takeda's new CFO

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

    Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief financial officer (CFO), effective September 2, 2013.In his new role, M...Read more

  • Eisai seeks nod for cancer, epilepsy drug in S Africa

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2013

    Singapore: Japan-based Eisai has filed two products, Halaven (eribulin) for metastatic breast cancer and Fycompa (perampanel) for epilepsy, for approval with Medicines Control Council (MCC)...Read more

  • Otsuka schizophrenia drug seeks EMA nod

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Dec, 2012

    Singapore: Otsuka Pharmaceutical and H Lundbeck's submission of a marketing authorization application (MAA) for the approval of aripiprazole depot formulation has been accepted by the Euro...Read more

  • Santen to give $7.9 mn fund to Clearside

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

    Singapore: Santen, a wholly owned subsidiary of Japan-based Santen Pharmaceuticals, and Clearside Biomedical, announced that Santen, has made an investment in Clearside Biomedical and has ...Read more

  • Takeda partners with Wipro for IT solutions

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2014

    Singapore: India based information technology, consulting and outsourcing company, Wipro, has partenerd with Japan's Takeda Pharmaceutical to provide IT services across the oranization. As...Read more

  • Affymax, Takeda recall anemia drug Omontys

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 25 Feb, 2013

    Singapore: Affymax and Takeda Pharma decided to voluntarily recall all lots of Omontys (peginesatide) injection to the user level, as a result of new post-marketing reports regarding seriou...Read more

  • Astellas completes patient recruitment in drug trial

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Dec, 2012

    Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registration study SECURE. Isavuconazole is an investigational intravenous (IV)...Read more

  • EMA accepts market authorization plea for alogliptin

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 25 May, 2012

    Singapore: The European Medicines Agency has accepted a marketing authorization application for alogliptin, a selective dipeptidyl peptidase IV, or DPP-4, inhibitor for the treatment of typ...Read more

  • Daiichi Sankyo expands drug discovery program

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities and research institutions based in Japan, 'Take a New challenge for Dr...Read more

  • BioDiem granted Japanese patent for BDM-1

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Australian infectious disease therapy development company BioDiem has been granted a key Japanese patent for antimicrobial compound, BDM-I. The compund acts against a range of ...Read more